Back

Clinical study on the efficacy and safety of ketotifen in STEMI patients undergoing primary PCI

30 August 2026 (13:15 - 13:25)
Organised by: Logo
Congress Presentation Part of: Primary percutaneous coronary intervention in STEMI: new strategies to improve reperfusion and outcomes ST-Elevation Myocardial Infarction (STEMI) ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Pengxin Xie

Peking University Third Hospital, Beijing (China)

3 More presentations in this session

Presentation thumbnail
Timing matters: impact of early oral p2y12 pretreatment on ischemic outcomes and reperfusion in stemi patients undergoing primary pci
Mr A. Gasca (Cali, CO)
Abstract Slides Video
Presentation thumbnail
Bivalirudin versus heparin in high and low bleeding risk patients undergoing primary PCI for STEMI: pre-specified analysis from the BRIGHT-4 trial
Professor M. Qiu (Shenyang, CN)
Abstract Slides Video
Presentation thumbnail
Pre-reperfusion dapagliflozin does not reduce infarct size in STt-elevation myocardial infarction: a randomized controlled trial
Assistant Professor K. Leemasawat (Chiang Mai, TH)
Abstract Slides Video

Access the full session

Session thumbnail
Primary percutaneous coronary intervention in STEMI: new strategies to improve reperfusion and outcomes
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Session
Novel pharmacological approaches following an acute coronary syndrome
1 September 2025
thumbnail
Congress Presentation
Randomized trial of deferred stenting with apixaban in high thrombus burden stemi using 3d echocardiography
29 August 2026
thumbnail
Congress Presentation
Effect of pre-hospital pulse-dose glucocorticoid on infarct size in st-segment elevation myocardial infarction: a randomized, blinded, placebo-controlled clinical trial
30 August 2024
thumbnail
Congress Presentation
Comparative effectiveness of ticagrelor versus clopidogrel in older adults (≥75 years) with ST-segment elevation myocardial infarction: a target trial emulation study
31 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources